Clinical Trial Update: Studying the Effects of Administration of Polyunsaturated Fatty Acids (PUFAS) of Omega-3 Series in Nicotine Dependence [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating omega-3 polyunsaturated fatty acids for nicotine dependence has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Dependence

Drugs mentioned

• PUFAS Omega-3 Series (polyunsaturated fatty acids (omega-3))

Snippet

Sponsor: Federal University of São Paulo | Conditions: Tobacco Dependence, Nicotine Dependence | Phase 3 | Status: COMPLETED | Results posted: 2020-10-14